Orion Portfolio Solutions’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-31,931
Closed -$148K 670
2021
Q2
$148K Buy
31,931
+1,320
+4% +$5.33K 0.01% 599
2021
Q1
$144K Buy
30,611
+4,715
+18% +$21.3K 0.01% 538
2020
Q4
$74K Buy
25,896
+11,699
+82% +$42.6K ﹤0.01% 490
2020
Q3
$55K Buy
+14,197
New +$77.8K ﹤0.01% 439

Other funds holding NNVC

Orion Portfolio Solutions's NNVC Position: Q3 2021 in Review

Orion Portfolio Solutions sold out of NanoViricides (NNVC) in Q3 2021, closing a stake of 31,931 shares — an estimated $148K sold.

Orion Portfolio Solutions first reported a position in NNVC in Q3 2020 and held it in 4 quarters. The position peaked at $148K in Q2 2021. 33 funds tracked by Wall St. Rank hold NNVC as of Q3 2021.

  • Orion Portfolio Solutions reported no remaining NanoViricides position as of Q3 2021 after selling out during the quarter.
  • Orion Portfolio Solutions sold 31,931 NanoViricides shares in Q3 2021, an estimated $148K.
  • Orion Portfolio Solutions first reported a position in NanoViricides in Q3 2020 and held it in 4 quarters.
  • Orion Portfolio Solutions's NanoViricides position peaked at $148K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held NanoViricides as of Q3 2021.

Based on Orion Portfolio Solutions's 13F filing for Q3 2021, filed 10 Nov 2021.